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Cyclin	E	is	often	overexpressed	in	cancer	tissue,	leading	to	genetic	instability	and	aneuploidy.	Cullin	3	(Cul3)	
is	a	component	of	the	BTB-Cul3-Rbx1	(BCR)	ubiquitin	ligase	that	is	involved	in	the	turnover	of	cyclin	E.	
Here	we	show	that	liver-specific	ablation	of	Cul3	in	mice	results	in	the	persistence	and	massive	expansion	of	
hepatic	progenitor	cells.	Upon	induction	of	differentiation,	Cul3-deficient	progenitor	cells	underwent	sub-
stantial	DNA	damage	in	vivo	and	in	vitro,	thereby	triggering	the	activation	of	a	cellular	senescence	response	
that	selectively	blocked	the	expansion	of	the	differentiated	offspring.	Positive	selection	of	undifferentiated	
progenitor	cells	required	the	expression	of	the	tumor	suppressor	protein	p53.	Simultaneous	loss	of	Cul3	and	
p53	in	hepatic	progenitors	turned	these	cells	into	highly	malignant	tumor-initiating	cells	that	formed	largely	
undifferentiated	tumors	in	nude	mice.	In	addition,	loss	of	Cul3	and	p53	led	to	the	formation	of	primary	
hepatocellular	carcinomas.	Importantly,	loss	of	Cul3	expression	was	also	detected	in	a	large	series	of	human	
liver	cancers	and	correlated	directly	with	tumor	de-differentiation.	The	expression	of	Cul3	during	hepatic	
differentiation	therefore	safeguards	against	the	formation	of	progenitor	cells	that	carry	a	great	potential	for	
transformation	into	tumor-initiating	cells.
Introduction
A genetic alteration frequently observed in cancer tissue is the 
increased expression of cyclin E (1). For example, the majority 
of liver cancers express this protein at levels higher than in the 
surrounding normal tissue (2). Intriguingly, cyclin E is also able 
to induce DNA double-strand breaks, which may lead to genetic 
instability and aneuploid cells (3). Consistent with the impor-
tance of cyclin E in regulating cell proliferation and genetic sta-
bility, its expression levels are tightly controlled. In addition to 
transcriptional mechanisms, cyclin E levels are also regulated 
by posttranslational modifications that trigger the proteolytic 
degradation of cyclin E by cullin 1– or cullin 3–dependent (Cul1- 
or Cul3-dependent) ubiquitin ligases. Degradation of cyclin E by 
the Cul1-dependent ubiquitin ligase requires its interaction with 
the F-box protein Fbw7, which upon phosphorylation of cyclin E 
at T380 by GSK3 and T384 by cdk2 tightly binds to the protein 
and mediates its polyubiquitination and subsequent proteasomal 
turnover (4, 5). Mutations in Fbw7 have been shown to induce 
genetic instability, and certain types of human cancers such as 
T cell leukemias and cholangiocellular carcinomas frequently 
show alterations in this gene (6).
Loss of Fbw7 also affects stem cell proliferation by depleting 
hematopoietic stem cells due to active cell cycling and an increase 
in the rate of apoptotic cell death (7–9). Conversely, expression of a 
stabilized version of cyclin E that can no longer be degraded by the 
Fbw7-dependent E3 ubiquitin ligase results in an expansion of the 
pool of proliferating erythroid progenitors with a reduced ability 
to differentiate and an increase in the rate of apoptosis (10). These 
results point to a tissue-specific function of cyclin E turnover in 
the maintenance of stem cell homeostasis.
In addition to the Cul1-dependent degradation system, a 
second ubiquitylation complex that employs Cul3 is required 
for the turnover of cyclin E (11). Cul3 forms a complex called 
the BTB-Cul3-Rbx1 (BCR) ubiquitin ligase, which controls the 
degradation of several proteins, including cyclin E, the meiotic 
spindle formation factor Mei-1, the transcription factor Nrf2, 
the Ci/Gli transcription factor, and the dishevelled protein in 
the Wnt/β-catenin pathway (12–15). Loss of Cul3 in the mouse 
leads to early embryonic lethality, with some cell types showing 
increased levels of cyclin E (11). Ablation of Cul3 expression in 
adult mouse hepatocytes in vivo results in a strong increase in 
cell size and genetic instability in the Cul3-deficient liver cells 
(16). While these results point to a central role of the BCR com-
plex in maintaining cyclin E levels and cellular homeostasis, 
nothing is known about the role of Cul3 in stem cells. We there-
fore ablated the Cul3 gene using an α-fetoprotein–Cre transgene 
that induces Cre recombinase expression in the developing liver 
starting at day 9.5 post coitum (p.c.).
In this work, we describe the phenotype of mice in which the 
Cul3 gene was selectively deleted in liver tissue. We find that loss 
of Cul3 leads to a massive expansion of liver progenitor cells that 
undergo senescence upon induction of differentiation. This pro-
cess depends on the expression of cyclin E, which in differentiating 
cells induces DNA damage and subsequent activation of a p53-
dependent damage checkpoint. Simultaneous loss of p53 results 
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in the formation of highly aggressive tumor-initiating cells, which 
form hepatocellular carcinomas in situ and after transplantation. 
Differentiation-induced senescence therefore constitutes a new 
tumor suppressor mechanism in liver cells.
Results
Loss of Cul3 results in the accumulation of hepatic progenitor cells. To analyze 
the function of the Cul3-based E3 ubiquitin ligase in liver embryo-
genesis, we crossed Cul3loxP/loxP mice with a transgenic mouse line 
that expresses the Cre recombinase under the control of albumin 
regulatory elements and α-fetoprotein enhancers (AlfpCre) (17), 
which directs Cre recombinase expression to the liver starting at day 
9.5 p.c. Mice were born at normal Mendelian ratios but only survived 
until approximately 11 weeks after birth. Most Cul3loxP/loxP AlfpCre 
mice were significantly smaller than their wild-type littermates, and 
all of them showed an up to 30% decrease in body weight at the 
time of death (data not shown). Upon macroscopic examination, 
we found that the livers of Cul3loxP/loxP AlfpCre mice were larger and 
appeared pale and of firm consistency (Figure 1A) compared with 
wild-type control organs. Microscopic analysis of the liver tissue 
and pathological findings revealed an almost complete loss of the 
normal liver architecture, with a decrease in liver parenchyma and 
areas of dysmorphic-appearing hepatocytes. These were surrounded 
by small mononucleated cells of oval or round shape (Figure 1A), 
which formed strand-like areas of cells that traversed the liver tis-
sue. In addition, we detected a strong increase in connective tissue 
(Supplemental Figure 1A; supplemental material available online 
with this article; doi:10.1172/JCI41959DS1), which contributed to 
the increase in consistency of the Cul3loxP/loxP AlfpCre livers. None of 
these changes were observed in wild-type liver tissue. To differenti-
ate Cul3-knockout cells from infiltrating stromal cells, lymphocytes, 
and macrophages, which were all identified on histological exami-
nation of the liver tissue, we generated triple transgenic mice by 
crossing Cul3loxP/loxP AlfpCre mice to β-galactosidase reporter mice 
(Rosa26-LacZ). Given that Cre recombinase expression is under the 
control of albumin regulatory elements and α-fetoprotein enhanc-
ers, LacZ expression should only be detectable in cells of hepatic ori-
gin. As shown in Figure 1B, β-galactosidase activity was detectable 
in the small mononucleated cells and in the remaining hepatocytes, 
indicating that Cre-mediated activation of LacZ expression was suc-
cessful in these cells in vivo. To further confirm that the activation 
of the Cre recombinase led to the loss of Cul3, we performed Cul3 
Western blot and immunofluorescence analyses of Cul3 expression 
in primary liver tissues. While whole liver lysates showed a loss of 
Cul3 at 4 weeks after birth, we could detect a small increase in pro-
tein levels from 4 to 8 weeks (Supplemental Figure 1C). We therefore 
performed immunofluorescence stainings for the Cul3 protein and 
found that Cul3 expression was undetectable in hepatocytes and in 
the mononucleated cells (Supplemental Figure 1D). The increase 
in Cul3 protein at 8 weeks was therefore caused by an increase in 
stromal cells, as shown in Supplemental Figure 1A. In addition, we 
used albumin staining to analyze whether albumin is also expressed 
in these small mononucleated cells. Using spleen as a negative con-
trol (Supplemental Figure 1B), we show that the AlfpCre transgene 
is only active in the small mononucleated cells and in hepatocytes, 
indicating that the cells in which Cul3 had been deleted were of 
hepatic origin (Figure 1A).
Our histological examination suggested that the population of 
small albumin-expressing cells in the Cul3-knockout livers might 
constitute undifferentiated hepatic progenitor cells that had 
expanded in number upon loss of Cul3. To determine the identity 
of these cells, we used a panel of antibodies directed against sur-
face epitopes frequently found on liver progenitor cells (18, 19). 
We found that the small mononucleated cells in the Cul3-knock-
out livers were to varying degrees positive for CK14, CD133, or 
CD34 expression (Figure 1C), pointing to an increase in the num-
ber of progenitor cells in Cul3-knockout livers as compared with 
wild-type organs. These stainings were confirmed by Western blot 
analysis of whole liver lysates in which the same stem cell markers 
could also be detected (Supplemental Figure 2A).
Activation of the liver stem cell pool is frequently found under 
conditions in which liver cell proliferation is blocked (20). Under 
such conditions, a population of bipotential liver progenitor cells 
called oval cells expands and differentiates into mature hepatocytes 
to restore liver function (21). However, when we compared tissue 
sections from 4- and 8-week-old livers, we detected a reduction in 
the number of hepatocytes (Figure 1D) in the Cul3-knockout mice. 
We used β-catenin to stain the plasma membrane of these cells, 
which showed features typical of hepatocytes, thereby allowing us 
to distinguish them from the small mononucleated cells (Supple-
mental Figure 1E). In contrast to the hepatocytes, the number of 
cells expressing the stem cell markers CD34 and CD133 increased 
over time (Figure 1E), while the CK14-positive cells did not. Our 
analysis therefore shows that loss of Cul3 in liver tissue results in 
a massive expansion of the pool of liver progenitor cells that fail to 
adequately differentiate into mature hepatocytes.
Loss of Cul3 causes DNA damage in differentiated liver cells but not in 
hepatic precursors. Next we analyzed why loss of Cul3 results in a 
block of cellular differentiation. Cul3 had previously been shown 
to regulate the stability of cyclin E (11). We therefore measured the 
expression level of cyclin E and found it to be strongly increased in 
Cul3loxP/loxP AlfpCre as compared with Cul3loxP/loxP liver cells (Figure 
2A). In addition to cyclin E, we found the levels of Aurora B kinase, 
another known Cul3 substrate (22), and of the cyclin kinase inhibi-
tor p21 to be increased in these livers. Importantly, cyclin E levels 
in Cul3-deficient livers were much higher than what we observed 
under conditions of liver regeneration, in which up to 90% of all 
hepatocytes synchronously entered the cell cycle, indicating that the 
increased expression of cyclin E in Cul3-deficient livers is not simply 
the result of increased cell proliferation (Supplemental Figure 2B).
Overexpression of cyclin E has been shown to induce DNA dam-
age (3, 23), which can activate a p53-dependent checkpoint (24). 
To quantitate the extent to which progenitor cells and differenti-
ated cells undergo DNA damage in response to the loss of Cul3 in 
vivo, we determined the levels of Ser139 phosphorylated histone 
H2AX (γ-H2AX), a marker for DNA double-strand breaks in livers 
from Cul3loxP/loxP AlfpCre mice, in wild-type livers and in livers 
expressing only the Cre recombinase, as embryonic fibroblasts 
from such mice were shown to display signs of DNA damage as a 
result of Cre recombinase expression (25). As shown in Figure 2B, 
γ-H2AX expression was detectable only in Cul3-deficient livers but 
not in wild-type livers or in mouse livers that express only the Cre 
recombinase. To confirm these results, we also performed Western 
blot analyses, as shown in Supplemental Figure 2C. We then per-
formed costainings of stem cell markers and γ-H2AX to identify 
the cell type that showed the highest levels of DNA damage. For 
these experiments, 100 cells from 3–4 mice of each age group were 
scored. As shown in Figure 2C, only 20% of the CD34-positive cells 
showed signs of DNA damage, while up to 70% of hepatocytes were 
positive for γ-H2AX. CK14-positive cells that had maintained the 
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small oval-shaped morphology (Figure 2D) showed intermediate 
levels of γ-H2AX positivity. In contrast, CK14-positive cells that 
were larger and more resembled liver cells accumulated DNA dam-
age to the same extent as hepatocytes.
DNA damage can result in cellular responses such as apoptosis or 
cellular senescence (26, 27). In contrast to previous reports in which 
loss of the Fbw7 protein or stabilization of cyclin E resulted in a sig-
nificant increase in apoptotic cell death (7, 10), we failed to detect 
increased numbers of apoptotic cells in Cul3loxP/loxP AlfpCre livers 
(data not shown) and therefore tested whether these cells might 
undergo senescence instead. As shown in Figure 2E, we found that 
Cul3loxP/loxP AlfpCre mice show strongly elevated levels of p16ink4a 
and p15ink4b at 4 and 8 weeks after birth as compared with wild-
type mice. In line with our finding that loss of Cul3 leads to DNA 
damage in differentiated cells, we found that CD34-positive cells 
were largely negative for the expression of the senescence associated 
marker p16, indicating that these cells are not affected by the loss 
of Cul3 (Figure 2F) and therefore did not undergo senescence in 
vivo. Together these results suggest that loss of Cul3 results in DNA 
damage in differentiated hepatocytes, which ultimately undergo 
senescence, while CD34-positive liver progenitor cells retain their 
proliferative potential and expand in number over time.
Induction of differentiation induces senescence and cell cycle exit in 
Cul3-deficient progenitor cells. To further analyze the relationship 
between senescence and differentiation in Cul3-deficient cells, we 
isolated Cul3-knockout cells from livers of Cul3loxP/loxP AlfpCre 
mice (see Methods for details). As shown in Supplemental Fig-
ure 3A, a shortened fragment (Δ3–7) of the genomic Cul3 gene, in 
which exons 3–7 of the Cul3 gene were deleted, can be detected by 
RT-PCR in these cell lines. The isolated cell lines expressed the same 
stem cell markers as those detected in the Cul3loxP/loxP AlfpCre liv-
ers from which they originated (Supplemental Figure 3B). Because 
the CD34-positive fraction retained its proliferation capacity in 
vivo, we analyzed these CD34-positive cells in more detail. For this 
we separated the CD34-positive fraction from CD34-negative cells 
by cell sorting and determined the expression of different surface 
markers. As shown in Supplemental Figure 3C, CD34-positive cells 
were positive for c-kit and CK14 and expressed AFP, albumin, and 
the shortened version of the Cul3 transcript Cul3 Δ3–7. These cells 
are negative for CD133 and express CK19 at low levels. To date, 
we have derived a total of 5 independent Cul3-knockout lines and 
have maintained them in culture for more than 12 months.
Using these cell lines, we established an in vitro differentiation 
system to analyze the molecular mechanism involved in this process 
in isolated progenitor cells. For this, we treated Cul3-knockout cells 
with medium supplemented with different growth factors known 
to induce hepatic differentiation in vitro (28). As shown in Figure 
3A, asynchronously growing Cul3-knockout cells expressed CD34 
and AFP, indicative of their precursor status. Upon treatment with 
differentiation medium, both markers were no longer detectable 
by RT-PCR, while at the same time Cul3-knockout cells started to 
induce the expression of genes associated with hepatocellular dif-
ferentiation. The hepatocyte-specific transcription factor PXR (29) 
was strongly induced at 48 hours after cultivation in differentia-
tion medium, followed by the induction of liver-specific transcrip-
tion factors such as HNF1/4α and CCAAT enhancer binding pro-
tein α (C/EBPα) and albumin (30) (Figure 3A). Importantly, upon 
differentiation, the vast majority of cells also changed their mor-
phology from a small cell containing little cytoplasm to a cell that 
showed the typical hepatocyte morphology and glycogen deposi-
tion (Supplemental Figure 4A) (31). Next we determined the per-
centage of cells staining positive for γ-H2AX in the differentiating 
cells as compared with asynchronously growing Cul3-deficient 
progenitor cells. As shown in Figure 3B, induction of differentia-
tion led to a significant increase in the percentage of γ-H2AX–posi-
tive cells, while the number of proliferating cells as measured by 
BrdU uptake was simultaneously decreasing (Figure 3C). In line 
with the induction of senescence in Cul3-deficient livers in vivo, we 
found that 96 hours after the induction of differentiation, Cul3-
deficient cells ceased to proliferate and entered a senescent state as 
measured by β-galactosidase stainings, p15ink4b and p16ink4a induc-
tion (Figure 3D and Supplemental Figure 4B), and accumulation 
of p53 (Supplemental Figure 4C). Given that the liver progenitor 
cells that we describe here only arise in Cul3-knockout livers, we 
decided to reconstitute Cul3 expression in the undifferentiated 
Cul3-deficient cells. Supplemental Figure 4, D and E, show that 
upon induction of differentiation, these cells do not accumulate 
DNA damage, nor do they become senescence.
Interestingly, we found that CD34 expression was reaccumulat-
ing at 72–96 hours after the induction of differentiation (Figure 
3A), while expression of other stem cell markers such as CK14, 
c-kit, and CD133 decreased within this time course (Supplemen-
tal Figure 4F). To understand the reasons for the reaccumula-
tion of CD34-positive cells, we pulse-labeled the cultures with 
BrdU and performed double labelings for BrdU and CD34. Upon 
induction of differentiation, we found a strong decrease in the 
number of CD34-positive cells that took up BrdU. Approximate-
ly 99% of the whole stem cell population was differentiating, 
and just a small fraction of CD34-positive cells remained in the 
cell cycle. At 72 hours and 96 hours, between 20% and 30% of the 
CD34-positive cells had reentered S phase as measured by BrdU 
uptake, which indicates that CD34-positive cells are able to 
resist differentiation-induced senescence (Figure 3E). As shown 
in Figure 3F, these reaccumulating CD34-positive cells did not 
show signs of DNA damage.
Figure 1
Loss of Cul3 leads to accumulation of hepatic progenitor cells in the 
liver. (A) Livers from Cul3loxP/loxP AlfpCre mice were harvested at 4 
and 8 weeks after birth. The livers showed a pale discoloration and 
firm consistency. Upon microscopic analysis, hepatocytes could be 
distinguished from small mononucleated cells. Arrow indicates small 
mononucleated cells in strands (compare inset) that surround hepa-
tocytic fields. (B) LacZ stainings in Cul3loxP/loxP AlfpCre Rosa26-LacZ 
mice were used to analyze the functionality of the Cre recombinase. 
Scale bars: 50 μm; 20 μm (insets). (C) Immunofluorescence and 
immunohistochemical detection of progenitor-associated surface 
markers CK14, CD34 (first and third columns), and CD133. In wild-
type livers, CK14-positive cells are primarily localized around bile ducts 
(compare arrows). CD34- and CD133-positive cells can only be found 
in Cul3-knockout livers (compare arrows that indicate positive cells in 
the strands). Cells also expressed the hepatocyte marker albumin. In 
the albumin staining, arrows indicate small mononucleated cells in the 
strands positive for albumin. Images in the second and fourth columns 
display the DAPI staining of the respective areas. Scale bars: 10 μm 
(top panels); 50 μm (bottom panels). (D) Quantification of hepatocytes 
in livers from Cul3loxP/loxP AlfpCre mice. H&E sections and β-catenin 
stainings (compare Supplemental Figure 1E) were used to quantitate 
the number of hepatocytes in the livers. For each quantification, 3–4 
mice were analyzed. (E) Quantification of progenitor cells positive for 
CD34, CD133, and CK14 at 4 and 8 weeks after birth. For each quan-
tification, 3–4 mice were analyzed. **P < 0.005.
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These in vitro findings therefore recapitulate our observation in 
the Cul3-knockout mice in vivo, namely that CD34-positive Cul3-
deficient cells are resistant to the differentiation-induced DNA dam-
age that forces the remainder of the population into senescence.
Cyclin E turnover is differentially regulated in liver progenitor cells and 
hepatocytes. Cyclin E turnover requires the activity of the BCR ubiquitin 
ligase. Our results regarding the induction of DNA damage in 
differentiated cells but not in hepatic progenitor cells suggested 
that the dependency on Cul3 activity depends on the differ-
entiation stage of the cell. We therefore determined the half-life 
of cyclin E in asynchronously growing cells and compared it with 
the half-life of cyclin E in differentiating Cul3-deficient cells. 
As shown in Figure 4A, cyclin E had a half-life of approximately 
5 hours in asynchronously proliferating cells, while 24 hours after 
induction of differentiation, cyclin E was no longer degraded. In 
contrast, reexpression of Cul3 resulted in normal degradation of 
cyclin E (Supplemental Figure 4G), leading to a decrease in overall 
cyclin E levels after 48 hours of differentiation (Supplemental Fig-
ure 4E). This indicates that the loss of Cul3 prevents the turnover 
of cyclin E specifically in differentiating cells.
As asynchronously growing Cul3-deficient cells showed no signs 
of DNA damage, we wondered whether these cells might be resistant 
to cyclin E–induced DNA damage or might not be able to respond 
to genotoxic stress altogether. However, after transfecting Cul3-
deficient cells with a cyclin E–expressing plasmid, we detected signs 
of DNA damage (γ-H2AX positivity) in the cyclin E–overexpressing 
Figure 2
Differentiation of Cul3-knockout 
hepatic progenitor cells leads to the 
induction of DNA damage and cellular 
senescence. (A) Western blot analy-
sis of known Cul3 substrates cyclin E, 
Aurora B, and p21 at 4 and 8 weeks 
after birth. Arrow indicates the cyclin 
E band. Actin was used as a loading 
control and was performed as noted in 
the methods section. Noncontiguous 
lanes from the same blot were spliced. 
Numbers indicate the different mice 
analyzed. (B) Immunofluorescence 
staining of γ-H2AX in Cul3-knockout 
and wild-type mice positive and nega-
tive for Cre recombinase. Arrows in 
Cul3loxP/loxP AlfpCre (Cul3 KO) livers 
indicate cells that accumulated DNA 
damage. In wild-type Cre+ and Cre– 
livers, no γ-H2AX (left panels) staining 
can be detected (compare Supplemen-
tal Figure 2C). DAPI staining is shown 
in the right panels. (C) Quantification 
of DNA damage in CD34-, CD133-, 
and CK14-positive cells (at least 100 
cells from 3–4 mice were analyzed). 
The graph shows quantification of 
double-positive cells. (D) Representa-
tive pictures of round- and oval-shaped 
CK14-positive cells (left panels). DAPI 
is shown in the right panels. CK14-
positive cells cannot be found in wild-
type livers. (E) Western blot analysis 
for senescence-associated markers 
p15 and p16 in whole liver lysates in 
Cul3loxP/loxP AlfpCre livers at 4 and 8 
weeks after birth in comparison with 
wild-type liver lysates, in which no p15 
or p16 could be detected. Numbers 
indicate the different mice analyzed. 
Noncontiguous lanes from the same 
blot were spliced. (F) Quantification of 
the expression of p16 in different liver 
cells at 4 and 8 weeks (200 CD34- or 
CK14-positive cells in 3 independent 
experiments). Hepatocytes were iden-
tified by typical morphology (Supple-
mental Figure 1E). Scale bars: 10 μm. 
*P < 0.05, **P < 0.005.
Downloaded from http://www.jci.org on January 11, 2016.   http://dx.doi.org/10.1172/JCI41959
research article
	 The	Journal	of	Clinical	Investigation   http://www.jci.org   Volume 120   Number 11   November 2010 3825
Cul3-negative cells (Figure 4B). We were also able to induce DNA 
damage and phosphorylation of Chk1 when we treated Cul3-
knockout progenitor cells with the DNA-damaging agent H2O2 in 
vitro (Figure 4C) or injected Cul3loxP/loxP AlfpCre mice with doxo-
rubicin (Supplemental Figure 5A), indicating that DNA damage 
response mechanisms are intact in Cul3-deficient progenitor cells.
These data suggested that the activity of the Cul3-dependent BCR 
E3 ligase is dispensable in progenitor cells but that cyclin E levels 
still need to be tightly controlled. We therefore wondered whether 
loss of the FBW7-dependent Skp1, Cullin1, F-box protein contain-
ing complex (SCFFBW7) E3 ubiquitin ligase might affect cyclin E 
levels and genetic stability in these cell lines. Knockdown of Fbw7 
or Cul1, components of the Fbw7-dependent SCF complex in asyn-
chronously growing Cul3-deficient cells, led to a complete stabili-
zation of cyclin E (Figure 4D). The knockdown was confirmed by 
RT-PCR (Figure 4E). Importantly, these cells also showed signs of 
DNA damage upon loss of Fbw7 or Cul1 (Figure 4F). To determine 
whether the accumulation of cyclin E was indeed responsible for the 
observed induction of DNA damage, we transfected Cul3-deficient 
progenitor cells with siRNAs targeting cyclin E1 and cyclin E2 and 
Figure 3
In vitro differentiation of progenitor cells recapitulates the in vivo phenotype. (A) RT-PCR analysis of progenitor cell– and hepatocyte-specific 
markers in asynchronous (as) cells and at different time points during differentiation (Diff.). Noncontiguous lanes from the same gel were 
spliced. (B) Quantitation of γ-H2AX staining by immunofluorescence at the indicated time points after the induction of differentiation. At least 3 
independent experiments were analyzed. Asynchronously growing cells were set as 100%. (C) Quantitation of cells in S phase by BrdU uptake 
(experiments were performed in triplicate). (D) Hepatic progenitor cells induce senescence upon differentiation. Western blot analysis during 
differentiation shows a strong accumulation of the senescence-associated marker p15. Progenitor cells from Cul3loxP/loxP AlfpCre mice stain posi-
tive for β-galactosidase at pH 5.8 at 96 hours after the induction of differentiation. All experiments were repeated 3–4 times. Actin was used as 
a loading control and analysis performed as noted in Methods. Noncontiguous lanes from the same blot were spliced. (E) Analysis of prolifera-
tion of CD34-positive cells during differentiation by quantification of CD34/BrdU. Proliferation of CD34-positive cells in asynchronously growing 
culture is also shown (n = 2). (F) Immunofluorescence γ-H2AX staining of CD34-positive cells at 96 hours of differentiation. Squares indicate 
CD34-positive cells, showing that these do not accumulate DNA damage. Scale bars: 50 μm. *P < 0.05, **P < 0.005.
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determined the number of γ-H2AX–positive cells. The knockdown 
of the cyclin E protein was confirmed by Western blotting. While 
differentiating Cul3-knockout cells still underwent DNA damage, 
we found that knockdown of cyclin E led to a significant reduction 
in the number of cells showing DNA damage as compared with 
untransfected controls (Figure 4G). Our data suggest that loss of 
Cul3 in progenitor cells is not sufficient to induce cyclin E–depen-
dent DNA damage or interfere with the ability of liver progenitor 
cells to self-renew. These undifferentiated cells nevertheless need 
to control cyclin E stability through the activity of the SCFFbw7 E3 
ubiquitin ligase. However, upon induction of differentiation, Cul3 
activity becomes critical, which then forces the Cul3-deficient cells 
to activate their DNA damage response and exit the cell cycle. These 
results suggested that the SCFFbw7 E3 ubiquitin ligase and the BCR 
ubiquitin ligase must be differentially regulated in liver progeni-
tor and differentiating cells. In line with this conclusion, we found 
that Fbw7 transcripts are strongly downregulated in differentiat-
ing liver progenitor cells (Figure 4H). Fbw7 expression decreases 
significantly between 12 and 24 hours of differentiation (compare 
also Supplemental Figure 5B). Conversely, the shortened message 
Figure 4
Accumulation of cyclin E in differentiating hepatic progenitor cells is responsible for the accumulation of DNA damage. (A) Cyclin E half-lives during 
differentiation and in asynchronously proliferating cells. At 24 hours of differentiation, cyclin E accumulates (experiments were performed in tripli-
cate). (B) Overexpression of myc-tagged cyclin E in asynchronously growing cells from Cul3loxP/loxP AlfpCre mice and quantitation of DNA damage 
(γ-H2AX). Immunofluorescence for myc tagged (MT)-cyclin E, γ-H2AX, and DAPI. Arrows indicate cyclin E–overexpressing cell positive for γ-H2AX 
(pink arrow) and an untransfected cell (white arrow) (n = 3). (C) Treatment of cells from Cul3loxP/loxP AlfpCre mice with H2O2 and analysis of DNA 
damage by γ-H2AX and pChk1 Western blots. (D) Measurement of cyclin E half-lives upon siRNA-mediated knockdown of Fbw7 and Cul1 in asyn-
chronously proliferating cells. Loss of Fbw7 and Cul1 increases cyclin E protein stability (n = 3/experiment). CHX, cycloheximide. (E) Confirmation 
of siRNA-mediated knockdown by RT-PCR. GAPDH was used as control. Noncontiguous lanes from the same gel were spliced. (F) Increased DNA 
damage as measured by γ-H2AX staining upon knockdown of Fbw7 and Cul1. For identification of transfected cells, a labeled siRNA control was 
cotransfected. (G) siRNA-mediated knockdown of cyclin E during differentiation and determination of DNA damage (γ-H2AX). Knockdown of cyclin 
E was confirmed by Western blotting. The arrow indicates the cyclin E band. c., scrambled siRNA control. Actin was used as a loading control and 
analysis performed as noted in Methods. Noncontiguous lanes from the same blot were spliced. The graph shows quantification of γ-H2AX–posi-
tive cells transfected with the indicated siRNAs 96 hours after the induction of differentiation (n = 3). (H) RT-PCR analysis of Fbw7 and Cul3 Δ3–7 
expression during differentiation of progenitor cells into hepatocytes at indicated time points. GAPDH was used as a control. *P < 0.05.
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derived from the deleted Cul3 locus (Cul3 Δ3–7) is constitutively 
expressed under these conditions (Figure 4H) and declined only to 
about 60% but then remained constant (compare also Supplemen-
tal Figure 5B). In accordance with the downregulation of Fbw7, we 
found Cul1, the E3 ligase component for the F-box protein Fbw7, 
also to be downregulated between 48 and 96 hours of differentia-
tion (Supplemental Figure 5C).
The loss of Cul3 therefore becomes critical only under condi-
tions of cellular differentiation, at which point the differenti-
ated cells are undergoing DNA damage–induced senescence. We 
therefore next asked whether the inactivation of the DNA dam-
age response pathway might convert the Cul3 deficient non- 
tumorigenic progenitor cells into tumor cells.
Loss of p53 collaborates with Cul3 deficiency to induce highly malignant 
tumor stem cells. The p53 protein is an important regulator of cel-
lular senescence and is also frequently mutated in human liver 
cell cancers (32). To analyze its role in the differentiation-induced 
senescence pathway, we crossed the Cul3loxP/loxP AlfpCre mice to 
a p53loxP/loxP mouse strain (33). As shown in Supplemental Fig-
ure 6A, Cul3/p53loxP/loxP AlfpCre double-knockout livers showed 
similar changes in liver architecture: residual hepatocytes and an 
accumulation of small mononucleated cells expressing the same 
markers as Cul3loxP/loxP AlfpCre livers (Supplemental Figure 6, B, 
D, and E). To test whether the induction of senescence observed 
in the Cul3-deficient livers is dependent on the expression of p53, 
we measured the expression of p16ink4a in primary liver tissue 
Figure 5
Maintenance of senescence by p53 
is essential for preventing the gen-
eration of tumor-initiating stem cells. 
(A) Quantitation of p16 expres-
sion in the indicated liver cells from 
Cul3/p53 double-knockout animals 
at 10–11 weeks after birth. Values 
are shown as difference relative 
to p16-positive cells in livers from 
Cul3 single-knockout animals 
(compare Figure 2F) (n = 3/group). 
(B) Quantitation of γ-H2AX expres-
sion in the indicated liver cells from 
Cul3/p53 double knockout animals 
at 10–11 weeks after birth. Values 
are shown as difference relative 
to γ-H2AX–positive cells in livers 
from Cul3 single-knockout animals 
(compare Figure 2C) (n = 3/group). 
(C) Quantitation of γ-H2AX staining 
by immunofluorescence at the indi-
cated time points after the induction 
of differentiation. Asynchronously 
growing cells were set as 100%. 
(D) Quantitation of S-phase cells by 
BrdU uptake at the indicated time 
points after the induction of differ-
entiation. (E) Comparative genomic 
hybridization analysis of Cul3 and 
Cul3/p53 double-knockout cells 
after induction of differentiation for 
96 hours compared with undifferen-
tiated cells of the identical genotype. 
*P < 0.05, **P < 0.005.
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from Cul3/p53 double-knockout mice. In contrast to Cul3 single-
knockout livers, we found significantly fewer CK14-positive cells 
that showed p16ink4a expression in the Cul3/p53 double-knock-
out livers (Figure 5A), while p16ink4a levels were not significantly 
different in CD34-positive progenitor cells or hepatocytes. As 
p21 also accumulated in these livers (Supplemental Figure 6C), 
we concluded that its expression depends on the induction of 
DNA damage but is independent of p53. To further analyze the 
proliferative potential of these different cell types, we treated the 
Cul3/p53loxP/loxP AlfpCre mice with CCl4 to induce liver regenera-
tion. As shown in Supplemental Figure 6F, only the CK14-posi-
tive cells showed a significant increase in BrdU uptake when com-
pared with CK14-positive cells in CCl4-untreated Cul3/p53loxP/loxP 
AlfpCre livers. These findings therefore indicate that the loss of p53 
results in decreased p16 expression in Cul3-negative, CK14-positive 
cells, which thereby retain their proliferative potential in vivo. 
Figure 6
Loss of p53 in Cul3-knockout progenitor cells leads to generation of tumor-initiating cells in vivo. (A) Transplantation of Cul3-knockout and 
Cul3/p53-knockout progenitor cells into nude mice. Shown is the average of 6 tumors from 3 mice after injection of 1 × 106 cells. P values for the 
increase in tumor size were calculated using the t test and are as follows: d 31/d 41, P = 0.0034; d 31/d 39, P = 0.744; d 39/d 48, P = 0.0022. 
(B) H&E staining of tumors derived from nude mice. CK14 and CD34 (bottom left panels) immunofluorescence staining to identify cells with 
stem cell characteristics. The bottom right panels show DAPI staining. Scale bars: 50 μm. (C) Primary hepatocellular tumors arise in Cul3/p53 
double-knockout livers (area indicated by arrow), while no tumors can be found in Cul3-knockout livers. For comparison, WT livers are shown. 
Scale bars: 200 μm. (D) Analysis of Cul3 and cyclin E protein levels in normal human liver tissue (nt) and hepatocellular carcinoma (HCC-G3) by 
immunohistochemistry. Original magnification, ×40. (E) HCC tissues show a strong downregulation of Cul3 and induction of cyclin E expression 
as measured by immunohistochemistry in normal human liver, dysplastic nodes, and hepatocellular cancers. De-differentiation of tumors cor-
related with the decrease in Cul3 protein (r = –0.375; P = 0.0001). Expression ranges from 0 (no expression) to 3 (strong expression). Increase 
in cyclin E protein levels and decrease in Cul3 protein levels correlated significantly upon de-differentiation of tumors (r = –0.476; P = 0.046).
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We did, however, detect a strong increase in the number of CK14 
cells that stained positive for γ-H2AX (Figure 5B). In line with 
these in vivo results, we found that isolated Cul3/p53 double-
knockout progenitor cells showed signs of DNA damage (Figure 
5C) upon induction of differentiation (Supplemental Figure 5D) 
but in contrast to Cul3 single-knockout cells failed to exit the cell 
cycle, as shown in Figure 5D. Together these results indicate that 
induction of p53 prevents cell cycle progression in differentiat-
ing Cul3-deficient CK14-positive progenitor cells and forces these 
cells into senescence.
To further substantiate these findings with regard to the forma-
tion of human liver cancers, we tested the role of Cul3 in the pre-
vention of DNA damage and the induction of senescence markers 
in human liver cancer cell lines. As shown in Supplemental Figure 
7A, a reduction in the expression of Cul3 in HepG2 cells through 
siRNA treatment led to an increase in the number of CD133-posi-
tive cells of about 25%. Loss of Cul3 was confirmed by RT-PCR 
(Supplemental Figure 7B). Moreover, asynchronously grow-
ing human CD133-positive cells in which Cul3 expression was 
decreased by siRNA treatment showed an increase in the S-phase 
fraction as measured by BrdU uptake when compared with control 
siRNA–treated CD133-positive cells (Supplemental Figure 7A).
HepG2 cells started to express liver differentiation markers 
such as HNF4α when treated with differentiation medium (Sup-
plemental Figure 7C), while at the same time expression levels of 
Fbw7 were decreasing and expression levels of Cul3 were increas-
ing. Next we tested whether loss of Cul3 during differentiation 
would lead to the induction of DNA damage as measured by 
the expression of γ-H2AX and induction of senescence mark-
ers. Supplemental Figure 7D shows that Cul3-deficient human 
cells indeed undergo DNA damage and start to express p15 after 
induction of differentiation.
As our studies in Cul3-deficient mouse liver progenitor cells sug-
gested that differentiation-induced DNA damage and senescence 
lead to the activation of a p53-dependent DNA damage response, 
we compared CD133-positive cells derived from a p53-positive 
(HepG2) cell line with CD133-positive cells that express a mutant 
version of p53 (HUH7). As shown in Supplemental Figure 7, E and F, 
only the p53 wild-type CD133-positive cells ceased to proliferate 
after the induction of differentiation, while p53 mutant CD133-
positive cells continued to take up BrdU. Together these findings 
support our finding derived from the study of Cul3-deficient 
mouse liver progenitor cells, namely that the expression of Cul3 
is required to prevent the formation of genetically unstable cells 
after the induction of differentiation.
Genetic instability is a hallmark of liver cancer development 
and increases as the tumor de-differentiates (34). To test whether 
the observed induction of double-strand breaks in differentiating 
Cul3-deficient hepatocytes would lead to the formation of geneti-
cally unstable cells, we performed comparative genomic hybrid-
ization analysis in Cul3 single- and Cul3/p53 double-knockout 
cells and compared their genetic composition before and after 
the induction of differentiation. Figure 5E shows that while Cul3-
knockout cells remained genetically stable, loss of p53 resulted in 
the induction of multiple chromosomal rearrangements as early 
as 96 hours after the induction of differentiation.
Cul3 is expressed at low levels in hepatocellular carcinomas. Our data 
show that loss of Cul3 predisposes hepatic progenitor cells to 
the induction of DNA damage. However, the induction of a p53-
dependent senescence mechanism blocks the proliferation of 
such cells, which limits their tumorigenic potential. In line with 
this conclusion, we found that Cul3-deficient hepatic progenitor 
cells fail to form tumors in nude mice, as shown in Figure 6A. We 
found that in contrast to the Cul3 single-knockout cells, all of 
the Cul3/p53 double-knockout lines we isolated formed tumors 
after transplantation into nude mice (Figure 6A). Importantly, as 
few as 100 Cul3/p53 double-knockout progenitor cells were suf-
ficient to form tumors (700–800 mm3), with a latency of approxi-
mately 70 days. Remarkably, the tumors generated by these cells 
did not grow in a confined position under the skin of the mouse, 
but often also infiltrated into the supporting muscle layers and 
into the peritoneal cavity.
Upon histological examination, we found highly malignant ana-
plastic tumors displaying variable aspects of hepatic and cholan-
giocytic development (Figure 6B). Immunohistochemical analysis 
revealed cells that were positive for CD34 but also large areas that 
did not stain for this marker, indicating the differentiation poten-
tial of the Cul3/p53 double-knockout cells from which the tumor 
originated. Next we tested whether loss of p53 in a Cul3-deficient 
mouse liver would also result in the formation of primary liver cell 
carcinomas. Microscopic examination of the Cul3/p53 double-
knockout livers at 11 weeks after birth revealed the presence of 
hepatocellular carcinomas in these mice, while none of the Cul3 
single-knockout mice developed liver tumors during their life span 
(Figure 6C). It is, however, important to note that the overall life 
span of the Cul3/p53 double-knockout mice was not different 
from that of the Cul3-knockout mice, indicating that the severe 
disruption of liver architecture was most likely responsible for the 
death of these animals and prevented the formation of large, mac-
roscopically visible liver cancers.
Based on our findings in the Cul3 mouse model, we asked 
whether loss of Cul3 expression might also contribute to liver 
carcinogenesis in humans. We therefore analyzed the expression 
levels of Cul3 in normal human liver tissue (n = 42), dysplastic 
liver nodes (n = 9), and malignant human liver cancers (n = 62). 
Given the importance of cyclin E dysregulation for the observed 
phenotypes in our mouse model, we also stained these tissues 
with antibodies specific for cyclin E. A representative example of 
these immunohistochemical stainings is shown in Figure 6D. A 
quantification of the results of this analysis is shown in Figure 
6E, in which Cul3 expression levels were assigned scores rang-
ing from 0 (no expression) to 3 (strong expression). This analysis 
revealed that in contrast to normal liver tissue or dysplastic nodes, 
tumor tissues expressed greatly reduced levels of Cul3 (r = –0.375; 
P = 0.0001). Conversely the expression levels of cyclin E were very 
low in normal liver tissue but significantly increased in tumor tis-
sues. Moreover, the increase in cyclin E protein levels and decrease 
in Cul3 protein levels correlated significantly upon de-differentia-
tion of tumors (r = –0.476, P = 0.046). Finally, we tested whether 
the observed correlation between Cul3 expression and differentia-
tion was specific to hepatocellular carcinomas or whether similar 
changes could be observed in cholangiocellular carcinomas as 
well. For this we analyzed Cul3 expression in cholangiocellular 
carcinomas using 67 CCC G2 and 84 CCC G3 tumors. In contrast 
to hepatocellular carcinomas, expression levels of Cul3 did not 
correlate with the de-differentiation process in cholangiocellular 
carcinomas when compared with Cul3 expression levels of nor-
mal cholangiocytes or of normal liver tissue (Supplemental Fig-
ure 6G). The role of Cul3 in tumorigenesis of the liver therefore 
seems to be restricted to hepatocellular carcinomas.
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Discussion
In this work we provide a mechanistic framework for explain-
ing how highly malignant liver cancers can arise from liver stem 
cells. We tested the importance of reduced Cul3 expression for 
liver tumorigenesis in a mouse model that allows the tissue-spe-
cific ablation of the Cul3 gene. Using this model system, we show 
that loss of the Cul3-based degradation system has two impor-
tant effects that promote the generation of liver tumors. First, it 
prevents the development of mature hepatocytes from hepatic 
progenitor cells. It is important to note that the block to dif-
ferentiation we observe in Cul3-deficient cells is not caused by a 
defect in a differentiation pathway but is instead a result of the 
activation of DNA damage response mechanisms specifically in 
differentiating but not in progenitor cells. Due to the existence 
of a redundant cyclin E ubiquitin ligase, the SCFFbw7 complex, 
progenitor cells are protected from the DNA damage–inducing 
activity of cyclin E accumulation. This difference in sensitivity to 
loss of Cul3 and therefore induction of DNA damage positively 
selects for the expansion of immature progenitor cells but drives 
differentiating cells into senescence. Nevertheless, this mechanism 
would arrest the development of Cul3-deficient progenitor cells 
by negatively selecting against the differentiated offspring. It is 
also interesting to note that while both cyclin E ubiquitylation 
complexes are expressed in undifferentiated mouse liver progeni-
tor cells, only the SCFFbw7 system is required for cyclin E turnover 
in these cells. Upon induction of differentiation toward mature 
hepatocytes, Fbw7 expression is transcriptionally downregulated. 
It is unknown why during liver cell differentiation a switch between 
the Fbw7- and the Cul3-dependent degradation systems occurs or 
which transcription factors might influence the expression of the 
Fbw7 gene. However, dual regulation of a substrate by SCF and 
Cul3-dependent degradation systems is not without example, as 
recent work demonstrates that the transcription factor cubitus 
interruptus, which is the downstream target of Hedgehog signal-
ing, is degraded by SCFSlimb/beta-TRCP and a Cul3-HIB–dependent E3 
ubiquitin ligases (13, 35). Interestingly, in eye imaginal discs, where 
Hedgehog signals coordinate cell proliferation and differentiation, 
the BTB protein HIB is highly expressed in the differentiating cells 
to prevent aberrant Hedgehog signaling activity and ensure nor-
mal eye development (35).
In addition to the differential effect the loss of Cul3 has on the 
induction of genetic damage in progenitor versus differentiated 
cells, its expression is critical for the ability of the differentiating 
cell to proliferate. In this work we show that after induction of 
differentiation, CD34-positive Cul3-deficient cells rapidly cease 
to proliferate and undergo senescence in vitro. This response 
depends on the induction of the p53 tumor suppressor protein. As 
we were unable to identify liver cancers in Cul3-deficient mouse 
livers or after transplantation of Cul3-deficient cells into nude 
mice, we conclude that the differentiation-induced senescence 
checkpoint efficiently protects from the development of liver 
cancer. However, loss of p53 is one of the most frequent genetic 
defects identified in human hepatocellular carcinomas (32). Spe-
cifically, long-standing liver inflammation, aflatoxin intoxication, 
and viral hepatitis–associated liver cancer are frequently associ-
ated with defects in the p53 tumor suppressor protein. We there-
fore tested whether the loss of Cul3 in hepatic progenitors would 
synergize with loss of p53 in the induction of hepatocellular car-
cinoma. Indeed, we found that loss of p53 completely abrogated 
the differentiation-induced senescence response of Cul3-deficient 
hepatic progenitors. Alternatively, Cul3/p53-deficient progenitor 
cells could undergo senescence in response to DNA damage but 
then due to the loss of p53 escape the senescence response and 
reenter the cell cycle. Our in vitro data, however, do not argue 
for such a mechanism, as in contrast to the Cul3-deficient cells, 
the Cul3/p53 double-knockout cells did not exit the cell cycle in 
response to the induction of differentiation. It is interesting to 
note that the induction of p21 is most likely not responsible for 
the observed cell cycle arrest in Cul3-deficient cells, as the Cul/p53 
double-knockout cells also showed increased levels of p21. The 
connection between the p53- and the p15/p16-dependent signal-
ing pathways therefore seems to be responsible for the observed 
changes in proliferation in the different mouse lines.
Importantly, not only did the Cul3/p53-deficient cells lose their 
ability to undergo cell cycle arrest, they also displayed severe chro-
mosomal alterations that were detectable as early as 96 hours after 
the induction of differentiation. Loss of p53 in differentiating 
Cul3-deficient progenitor cells therefore promotes the formation 
of highly malignant genetically unstable cancer cells. These cells 
display several features of cancer-initiating cells. After transplanta-
tion into nude mice, they form tumors at very low cell numbers. As 
few as 100 Cul3/p53-deficient cells were sufficient to form cancers 
in this model and were serially transplantable. Histological and 
immunohistochemical analysis of these tumors revealed highly 
pleomorphic tumors, which in addition to containing tumor cells 
that showed features of hepatocytic differentiation also contained 
the CD34-positive progenitor cells from which they originated.
Expansion of the number of liver progenitor cells that then dif-
ferentiate into mature hepatocytes is best characterized in animal 
models in which normal liver cell proliferation is blocked (36). 
Under such conditions, bipotential liver progenitor cells will 
expand in number and help to repopulate the damaged organ. 
This continuous proliferation will ultimately exhaust the regener-
ative potential of the mature hepatocytes and thus induce a com-
pensatory expansion of progenitor cells that attempt to replace 
damaged liver cells. We hypothesize that Cul3-deficient hepatic 
progenitor cells reside in the liver over a long period of time but 
only attempt to expand and differentiate into hepatocytes when 
the regenerative capacity of the liver is exhausted. Therefore, only 
when hepatocyte-based liver regeneration is sufficiently impaired 
do liver progenitor cells receive sufficient external signals to 
undergo differentiation. While liver cirrhosis is known to be a 
prerequisite for the formation of genetically altered hepatocytes 
that ultimately give rise to tumors, it might also be necessary for 
the formation of stem cell–derived liver cancers. This idea could 
explain why most liver cancers, even those with histologic features 
of stem cells, originate from cirrhotic livers.
The model that arises from our study predicts that defects such 
as the loss of Cul3 will lead to severe genetic damage in differenti-
ated cells but not in progenitor cells from which these cells origi-
nate. This difference is based on the differential expression of the 
SCFFbw7 and Cul3-BTB dependent ubiquitin ligases and selects for 
the expansion of undifferentiated progenitor cells while the differ-
entiated offspring undergo senescence. Cul3-deficient progenitor 
cells can persist in the liver only in their undifferentiated state but 
carry a high risk of malignant transformation. A second genetic 
alteration, such as the loss of p53, which is essential for maintain-
ing the senescence response activated by the loss of Cul3 in dif-
ferentiated cells, is sufficient to transform these cells into highly 
malignant tumor-initiating cells. In summary, our data provide 
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the framework for the identification of genes that by connecting 
differentiation and DNA damage responses in stem or progenitor 
cells allow for the formation of tumor-initiating cells.
Methods
Mouse work and tumor studies. All experiments were performed with the 
approval of the animal rights and protection agencies Niedersächsisches 
Landesamt für Verbraucherschutz und Lebensmittelsicherheit, Lower 
Saxony, Germany. Livers of Cul3loxP/loxP AlfpCre and Cul3/p53loxP/loxP Alf-
pCre mice were harvested at 4 and 8 weeks after birth. DNA, RNA, and 
protein extractions were done as previously described (37). Tumor studies 
were done as previously described (38). Tumor growth was determined for 
6 tumors of 3 mice for each genotype. To determine the minimum number 
of cells able to form a tumor in nude mice, Cul3/p53 hepatic progenitor 
cells were serially diluted to 100 cells per injection.
To analyze liver regeneration, we mixed CCl4 1:4 with mineral oil and 
injected 3.5 μl/g mouse intraperitoneally. After 48 hours, BrdU was inject-
ed 2 hours before sacrifice. Livers were harvested and fixed in PFA. Staining 
was performed as described below.
To analyze DNA damage responses of CD34-positive cells in Cul3loxP/loxP 
AlfpCre mice, we injected mice with doxorubicin (0.01 μg/g mouse). After 
48 hours, livers were harvested and fixed in PFA. Stainings were done as 
described below. Goldner staining was used to identify stromal cells.
Statistics. All statistical analyses were done using Prism software (GraphPad) 
(2-tailed t test). All graphs were created using Microsoft Excel software, and 
error bars were calculated with Excel. All data are represented as mean ± SD.
Western blot analysis. Tissue or liver lysates were generated as described pre-
viously (39). The protein concentration of all lysates was determined using 
the Bradford method (Bio-Rad) according to the manufacturer’s instruc-
tions. Samples were aliquoted, shock frozen in liquid nitrogen, and stored at 
–80°C. A test gel probed for actin was run to ensure correct quantification of 
protein concentrations. If necessary, protein concentrations were readjusted 
and determined again by the Bradford method and controlled by Western 
blotting using an actin-specific antibody. These aliquoted lysates were used 
for further analyses with specific antibodies. To ensure equal transfer of pro-
teins, gels were stained with Coomassie blue after blotting and membranes 
were analyzed with ink or Ponceau staining after exposure to the film.
Antibodies used for Western blotting were cyclin E (Delta Biolabs), actin 
(ICN), p21 (Santa Cruz Biotechnology Inc.), p16 (Biozol), ICAM1 (Abcam), 
Aurora B (Abcam), pChk1, p15 (Cell Signaling Technology), Cul3 (Santa 
Cruz Biotechnology Inc.), PKM2 (US Biological), CK14 (Progen), CD34 
(BioLegend), and CD133 (Abcam, 19898). Secondary antibodies were pur-
chased from Amersham.
Immunofluorescence staining/tissue array. Immunofluorescence staining 
of paraffin sections was performed using the following antibodies: CK14 
(Progen), CD34 (BioLegend), CD133 (Abcam, 19898), albumin (Acris), 
γ-H2AX (Upstate, clone JBW301), and p16 (Biozol, LS-C32847).
Stainings of paraffin sections were done as described below.
CK14 staining: Antigen unmasking was performed in Tris/EDTA buffer, 
pH 9.0, for 20 minutes. Slides were allowed to cool down slowly at room 
temperature. Sections were permeabilized in 0.3% Triton for 2 minutes 
and washed in PBS. Primary antibody was diluted 1:150 and incubated 
overnight at 4°C. Slides were washed in PBS, and secondary antibody was 
incubated for 1 hour at room temperature at a dilution of 1:400.
CD34 staining: Antigen unmasking was performed in Tris/EDTA buffer, 
pH 9.0, for 20 minutes. Slides were allowed to cool down slowly at room 
temperature. Sections were permeabilized in 0.3% Triton for 2 minutes, 
washed in PBS, and incubated with primary antibody (1:50) overnight at 
4°C. Slides were washed, and secondary antibody was used at a 1:100 dilu-
tion for 1 hour at room temperature.
CD133 staining: Antigen unmasking was performed in citrate buffer, 
pH 6.0, for 20 minutes. Slides were allowed to cool down slowly at room 
temperature. Antibody was incubated overnight at a dilution of 1:50. After 
washing in PBS, secondary antibody was incubated at a 1:100 dilution for 
1 hour at room temperature.
Cul3 staining: Antigen unmasking was performed in Tris/EDTA buffer, 
pH 9.0, for 20 minutes. Slides were allowed to cool down slowly at room 
temperature. Sections were permeabilized in 0.3% Triton for 2 minutes and 
washed in PBS. Endogenous peroxidase was blocked in 0.3% H202 for 20 
minutes. All other steps were done following the instructions of the TSA 
Kit (PerkinElmer). In short, unspecific binding was blocked using the TNB 
Buffer as described in the kit. Cul3 antibody (Santa Cruz Biotechnology Inc., 
H293) was diluted 1:100 and incubated overnight at 4°C. Secondary anti-
body (anti-rabbi–biotin [Dianova]) was incubated for 1 hour at room tem-
perature after the slides were properly washed in PBS. After washing, Strep-
tavidin-Peroxidase was used as supplied with the TSA kit (Perkin Elmer) and 
incubated for 1 hour. Fluorescence substrate was incubated for 5 minutes, 
and after washing slides were counterstained with DAPI and mounted.
γ-H2AX, p16 costaining: Antigen retrieval was performed in 10 mM citrate 
buffer (for γ-H2AX costainings) or in Tris/EDTA buffer, pH 9.0 (p16 costain-
ings). Unspecific binding was minimized by incubation of sections with 1% 
BSA or by using MOM blocking reagent (Vector). Quantitation of cells was 
done on 3 different sections of at least 3 mice. Stem cell markers were ana-
lyzed as described above.
BrdU staining: For BrdU staining, slides were deparaffinized and anti-
gen unmasking was performed in Tris/EDTA buffer. Double staining was 
performed using the Amersham Proliferation kit and CD34 and CK14 
antibodies.
For immunofluorescence detection of DNA damage of cells grown on 
coverslips, the Abcam antibody ab11174 was used. Cells were fixed in 4% 
PFA at the indicated time points for 3 minutes, washed in PBS, and per-
meabilized in 0.1% Triton for 5 minutes. Antibody incubation was done 
after blocking in 1% BSA/PBS for 1 hour. To analyze proliferation, the Cell 
Proliferation Kit (Amersham) was used according to the manufacturer’s 
instructions. Secondary antibodies for immunofluorescence were pur-
chased from Dianova. For quantitation of DNA damage and BrdU uptake, 
3 independent experiments were analyzed. All statistical analyses were 
done using the t test and Prism 5 statistics software.
Tissue microarray analysis of human normal tissue and HCC as well as 
statistical analysis have been described previously (40). The following scor-
ing system was used to represent quantity: 0, no expression; 1, positivity in 
less than 1% of tumor cells; 2, positivity in 1%–9% of tumor cells; 3, positiv-
ity in 10%–50% of tumor cells; 4, positivity in more than 50% of tumor cells. 
Antibodies used for Cul3 staining and cyclin E were purchased from Acris 
(HE12) and Delta Biolabs (C19).
LacZ staining. Cryosections were fixed in fixing solution (0.2% glutaral-
dehyde, 50 mM EGTA, pH 7.3, 100 mM MgCl2 in PBS). Staining was per-
formed overnight in staining buffer (0.5 mg/ml X-gal, 5 mM potassium 
ferrocyanide, 5 mM potassium ferricyanide in 2 mM MgCl2, 0.01% sodium 
deoxycholate, 0.02% Nonidet P40 in PBS; pH 7.3). The next day, section 
were washed in PBS, counterstained with hemalaun, and covered in Kai-
ser’s glycerogelatin. All pictures were taken with a DM5000B microscope 
(Leica) using the DFC300FX camera and Leica software.
Isolation of hepatic progenitor cells. Cells were isolated by chopping fresh 
mouse liver tissue in media containing 10% FCS. Supernatant and small 
liver pieces were transferred to a 10-cm culture dish and cultivated over-
night. The next day, half of the medium (5 ml) was replaced with fresh medi-
um. Cells were cultivated for 2–3 months, with half of the medium replaced 
every 3–4 days, until the plate was confluent. Cell lines were subjected to 
single clone expansion for RT-PCR and differentiation into hepatocytes.
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Differentiation of hepatic progenitor cells. Differentiation medium was prepared 
as described previously (28). The medium was further supplemented with 2% 
FCS and 40 ng/ml HGF (Sigma-Aldrich) and 20 ng/ml EGF (Sigma-Aldrich). 
For differentiation experiments, cells were seeded in 12-well plates coated with 
collagen (1 mg/ml; Roche) at a density of 3.2 × 104 cells/well. For analysis of 
cells by FACS sorting, CD34 staining was performed on living cells. Anti–rat 
Cy3 secondary antibody was used. Purity of sorted cells was 90%.
Differentiation of HepG2 and HUH7 cells was achieved by plating cells 
on collagen-coated plates. HGF, EGF, and dexamethasone were added to 
the medium.
siRNA knockdown of cyclin E1 and E2, FBW7, Cul1, and Cul3. The following 
siRNA molecules were purchased from Ambion: ccne1 ID 161045; ccne2 ID 
600056; Cul1: ID 70723; Cul3: ID 16050. Fbw7 knock down was achieved 
by using 3 different siRNAs targeting Fbw 7.
siRNA was transfected at a final concentration of 10 nM. Transfections 
were done according to the instructions for use (HiPerFect, QIAGEN). 
For identification of transfected cells, a labeled control siRNA was trans-
fected simultaneously. Transfection efficiency was approximately 90%. The 
knockdown was confirmed by RT-PCR using Fbw7 and Cul1 primers (see 
below for sequences).
For determination of cyclin E half-lives, transfection was done in asyn-
chronously proliferating cells 24 hours after seeding. Cycloheximide was 
added (final concentration, 10 mg/ml) 72 hours after seeding the cells. 
Samples were taken at the time points indicated. Western blot analysis was 
done for cyclin E, and protein bands were quantified using Bio-Rad Quan-
tification software (Quantity One).
HepG2 and HUH7 cells were transfected after seeding on a 6-cm plate 
using 20 nM Cul3 siRNA. After 48 hours, cells were labeled with BrdU for 
12 hours and then trypsinized for FACS analysis.
FACS analysis. HUH7 and HepG2 cells were transfected with siRNA and har-
vested after 60 hours. Cells were resuspended in 1% BSA, 1 mM EDTA in PBS, 
and Cd133 was stained using BD antibody 130-080-801. Cells were washed 
twice at 4°C and fixed using the BD Cytofix/Cytoperm Solution provided 
with the BrdU FITC Kit (51-2354AK). Analysis was done using FACSCalibur.
Transfection of progenitor cells. Cells were seeded at a density of 4 × 104 cells 
per well, which contained gelatin-coated coverslips. The next day, cells were 
transfected with Attractene from QIAGEN following the instructions for 
use. Twenty-four hours later, coverslips were fixed in PFA for 3 minutes 
and stained using myc-tag-specific antibody (Upstate).
Cul3 reconstitution. Cul3-knockout clones were transfected with linearized 
pCS2 Cul3 plasmid and the selection plasmid pBabe Puro using Polyfect 
transfection reagent according to the manufacturer’s protocol (Qiagen). 
Cells were selected with 2 μg/ml puromycin, and clones were selected for 
further analysis by Western blotting for Cul3.
Treatment with H2O2. Cells were seeded at a density of 4 × 104 cells per well 
on gelatin-coated coverslips. H2O2was added at a concentration of 350 μM. 
Cells were harvested 30 minutes after addition of H2O2 and analyzed by 
Western blotting.
cDNA synthesis and PCR. RNA extractions were done as previously 
described (37). Primers used to monitor differentiation of progenitor 
cells into hepatocytes were: HNF1α (29) dioxygenase, GST, CD34, Thy1 
(41), albumin and AFP (42), PXR (43), and c-kit (44). Primers used to 
amplify C/EBPα and HNF4α were as follows: C/EBPα forward 5′-AAAGC-
CAAGAAGTCGGTGGA-3′ and C/EBPα reverse, 5′-CAGTTCACGGCT-
CAGCTGTT-3′. HNF4α forward, 5′-CTTCCTTCTTCATGCCAG-3′ and 
HNF4α reverse, 5′-ACACGTCCCCATCTGAAG-3′. Primers used to ana-
lyze expression of p15 and p16 were as follows: p16 forward, 5′-CCGCTG-
CAGACAGACTGGC-3′; p16 reverse, 5′-TGAGGCCGGATTTAGCTCTG-3′; 
p15 forward, 5′-AGATCCCAACGCCCT-3′; p15 reverse, 5′-AGATCCCAAC-
GCCCT-3′. Primers for p21 were published previously (45).
Primers used for expression analysis of Fbw7 and Cul3 (wild-type and 
deleted version) were as follows: Fbw7 forward, 5′-CAAATCTCCTA-
AGGTGCTGAAAGGGCATG-3′ and reverse, 5′-CCACATGGATGCCAT-
CAAACTGTAATGAATAG-3′; Cul3 forward, 5′-ATAAATAAGGTGC-
GAGAAGAT-3′ and reverse, 5′-AGTCAAAGGGCTAACAGAAC-3′. For 
Cul3, PCR products were gel purified and sequenced by Agowa to confirm 
deletion of the Cul3 fragment.
Primers used to amplify human Cul3 were 5′-ATGACCATGGAT-
GAAAAATATG-3′ and 5′-CAATATTGTTTCTACTTCTTGTTCTG-3′. Cul1 
primers to analyze knockdown upon siRNA treatment were Cul1 forward, 
5′-CAAATCTTCTTAAGGATGGAGAAGATTTAATG-3′ and Cul1 reverse, 
5′-CAGCCCCAATTCCACATAAGATTG-3′.
PAS staining and β-galactosidase staining. Cells grown on coverslips were 
fixed in 4% PFA for 3 minutes, washed in PBS, and subjected to permea-
bilization in 0.1% Triton for 10 minutes. Cells were then washed in dis-
tilled water and treated with 1% periodic acid for 5 minutes. Cells were 
extensively washed with distilled water and incubated in Schiff reagent for 
10 minutes. After cells were washed with tap water, they were mounted in 
gelatin. To confirm specific staining of glycogen after permeabilization, we 
treated cells with 5 mg/ml diastase for 30 minutes at 37°C.
Senescence-associated β-galactosidase activity was analyzed by incubat-
ing cells in freshly prepared staining solution (1 mg/ml 5-bromo-4 chloro- 
3-indolyl β-d galactosidase in DMF/40 mM citric acid (pH 5.8), 5 mM 
potassium ferrocyanide, 5 mM potassium ferricyanide, 150 mM NaCl, and 
2 mM MgCl2). Cells were incubated at 37°C for 24 hours.
Array comparative genomic hybridization. Array comparative genomic 
hybridization was performed using Agilent Mouse Genome Microarray Kit 
244A (Agilent Technologies), a high-resolution 60-mer oligonucleotide-
based microarray with median probe spacing of about 6.4 kb. Labeling and 
hybridization of genomic DNA were performed according to the protocol 
provided by Agilent.
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